Press Information
KYOCERA to Expand Medical Product Development
By integrating manufacturing and R&D operations, company plans to strengthen
development of medical products including wearable and implantable devices.
Kyoto/London – November 28
th
, 2017. Kyocera Corporation (President: Hideo Tanimoto)
today announced plans to expand operations at its new Medical Development Center, which
opened in Japan’s Shiga Prefecture at the company’s Shiga Yasu Plant in April 2017. The new
Medical Development Center integrates medical product manufacturing and R&D operations for
Kyocera to aid in future innovations such as wearable and implantable devices.
The Kyocera Group offers a wide range of products and services in the medical sector —
including orthopedic / dental implants and electronic components for medical devices. To
maximize synergies in device-related businesses, Kyocera Medical Corporation, a former wholly
owned subsidiary, was merged into Kyocera Corporation in April this year. As part of the
consolidation, Kyocera is currently combining three Japan-based manufacturing operations for
medical devices into the Shiga Yasu Plant, and additionally established the Medical
Development Center which integrates R&D activities. Through the integration, the company
aims to unify manufacturing and R&D operations, and expand business in health and medical
markets in a speedy manner.
The company is increasing the development team and accelerating the development of medical
products such as wearable and implantable devices by leveraging its expertise as a producer of
components. Recent Kyocera developments include a miniaturized blood-flow sensor as well as
earbuds with this sensor build in. With the earbuds, the company is developing applications such
as monitoring health conditions while listening to music, and is also promoting the development
of new devices utilizing the blood-flow sensor. The company is also engaged in a collaborative
project with Kyoto University and Osaka University to develop a new cochlear implant.
Furthermore, Kyocera Communication Systems Co., Ltd. — a subsidiary which offers
information and communications technology (ICT) solutions — recently launched a joint
research with the University of Tsukuba to develop an Artificial Intelligence (AI) system capable
of detecting skin diseases by analyzing digital images of a patient’s skin. Through these
projects, the Kyocera Group aims to create various new businesses in the health and medical
field.